Skip to main content
SpringerLink
Log in

New Drugs in the Treatment of Borderline Personality Disorder

  • Chapter
Treatment of Personality Disorders

  • 342 Accesses

Abstract

From both a clinical and a neurobiological point of view, Borderline Personality Disorder (BPD) as defined by DSM-IV (A.P.A., 1994) must be considered an heterogeneous condition. Clinical studies on BPD patients showed that BPD diagnosis is rarely the only Axis II diagnosis present in a personality disordered patient, and broadly overlaps with other diagnoses pertaining to the three DSM category clusters (e.g. Nurnberg et al., 1991). Moreover, comorbidity with Axis I pathologies is often present: as reported in DSM-IV itself, heterogenous Axis I pathologies (such as mood disorders, substance-related disorders, eating disorders, post-traumatic stress disorders, and attention-deficit disorder) are commonly diagnosed in patients affected by BPD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akiskal H.S., Chen S.E., Davis G.C., Puzantian V.R., Kashgarian M., and Bolinger J.M. (1985) Borderline: an adjective in search of a noun. J Clin Psychiatry 46: 41–48.

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association. Diagnostic and statistic manual of mental disorders. 4rd ed. Washington, DC: A.P.A. Press;1994.

    Google Scholar 

  • Andrulonis D.A., Glueck B.C., Stroebel C.F. et al. (1981) Organic brain dysfunction in the borderline syndrome. Psychiatr Clin North Am 4:47–66.

    PubMed  CAS  Google Scholar 

  • Barratt E.S., Kent T.A., Bryant S.G. et al. (1991) A controlled trial of phenytoine in impulsive aggression (letter) J Clin Psychopharmacol 11: 388–389.

    CAS  Google Scholar 

  • Battaglia M., Perini Strambi L., Smirne S., Bernardeschi L., and Bellodi L. (1993) Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. Biol Psychiatry 33: 326–334.

    Article  PubMed  CAS  Google Scholar 

  • Battaglia M., Ferini Strambi L., Smirne S., Bemardeschi L., Oldani L., and Bellodi L. (1995) Cardiac autonomic fonction during sleep of never-depressed bordeline subjects: a pilot study. J Psychiatric Res 29: 397–405.

    Article  CAS  Google Scholar 

  • Battaglia M., Ferini Strambi L., Bertella S., Bajo S., and Bellodi L. (1998) First-cycle REM density in never-depressed subjects with borderline personality disorder. Biol Psychiatry, in press.

    Google Scholar 

  • Bellodi L., Battaglia M., Gasperini M., Scherillo P., and Brancato V. (1992) The nature of depression in borderline depressed patients. Compr Psychiatry 33: 128–133.

    Article  PubMed  CAS  Google Scholar 

  • Benedetti E, Sforzini L., Colombo C., Maffei C., and Smeraldi E. (1998) Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 59: 103–107.

    Article  PubMed  CAS  Google Scholar 

  • Bolton S. and Gunderson J.G. (1996) Distinguishing bordeline personality disorder from bipolar disorder: differential diagnosis and implications. Am J Psychiatry 153: 1202–1207.

    PubMed  CAS  Google Scholar 

  • Brinkley J.R., Beitman B.D., and Friedel R.O. (1979) Low-dose neuroleptic regims in the treatment of borderline patients. Arch Gen Psychiatry 36: 319–326.

    Article  PubMed  CAS  Google Scholar 

  • Casey P., Meagher D., and Butler E. (1996) Personality, functioning, and recovery from major depression. J Nery Ment Dis 184 (Suppl 4): 240–245.

    Article  CAS  Google Scholar 

  • Chengappa K.N.R., Baker R.W., and Sirri C. (1995) The successful use of clozapine in ameliorating severe self mutilation in a patient with borderline personality disorder. J Personality Disord 9 (1): 76–82.

    Article  Google Scholar 

  • Chopra H.D. and Beatson T.A. (1986) Psychotic Symptoms in Borderline Personality Disorder. Am J Psy-chiatry 143: 12.

    Google Scholar 

  • Coccaro E.F. (1989) Central serotonin and impulsive aggression. Br J Psychiatry 155: 52–62.

    Google Scholar 

  • Coccaro E.E, Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., and Davis K.L. (1989a) Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46: 587–599.

    Article  PubMed  CAS  Google Scholar 

  • Coccaro E.F., Siever L.J., Kavoussi R., and Davis K.L. (1989b) Impulsive aggression in personality disorder: evidence for involvment of 5HT1 receptors. Biol Psychiatry (Suppl) 25 (7A): 86A.

    Article  Google Scholar 

  • Coccaro E.F., Astill J.L., Herbert J.L., and Schut A.J. (1990) Fluoxetine treatment of impulsive aggression in DSM-IIIR personality disorder patients. J Clin Psychopharmacol 10: 373–375.

    Article  PubMed  CAS  Google Scholar 

  • Coccaro E.F. and Siever L.J. (1995) The neuropsychopharmacology of personality disorders. In: Bloom F.E. and Kupfer D.J., eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press; pp. 1567–1578.

    Google Scholar 

  • Coccaro E.F. (1998) Clinical outcome of psychopharmacologie treatment of borderline and schizotypal personality disordered subjects. J Clin Psychiatry 59 (Suppl 1): 30–35.

    Article  PubMed  Google Scholar 

  • Cornelius J.R., Soloff P.H., Perel J.M., and Ulrich R.F. (1990) Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 26: 151–154.

    PubMed  CAS  Google Scholar 

  • Cornelius J.R., Soloff P.H., Perel J.M., and Ulrich R.F. (1993) Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine Am J Psychiatry 150: 1843–1848.

    CAS  Google Scholar 

  • Coryell W.H. and Zimmerman M. (1989) Personality disorder in the families of depressed, schizophrenic and never-ill probands. Am J Psychiatry 146: 496–502.

    PubMed  CAS  Google Scholar 

  • Cowdry R.W., Pickard D., and Davies R. (1980) Limbic dysfunction in the borderline syndrome. In: New research abstracts,133rd annual meeting of american psychiatric association. Washington, DC, A.P.A. Press.

    Google Scholar 

  • Cowdry R.W. (1987) Psychopharmacology of Borderline Personality Disorder: A Review. J Clin Psychiatry 48 (Suppl 8): 15–22.

    PubMed  Google Scholar 

  • Cowdry R.W. and Gardner D.L. (1988) Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, tranylcypromine. Arch Gen Psychiatry 45: 111–119.

    Article  PubMed  CAS  Google Scholar 

  • De la Fuente J.M. and Lotstra F. (1994) A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacol 4 (4): 479–486.

    Article  Google Scholar 

  • De la Fuente J.M., Tugendhaft P., and Mavroudakis N. (1998) Electroenceplialographic abnormalities in borderline personality disorder. Psychiatry Res 77: 131–138.

    Article  PubMed  Google Scholar 

  • Faltus F.J. (1984) The positive effect of alprazolam in the treatment of three patients with borderline personality disorder. Am J Psychiatry 141: 802–803.

    PubMed  CAS  Google Scholar 

  • Frankenburg F.R. and Zanarini M.C. (1993) Clozapine treatment of borderline patients: a preliminary study. Comprenhens Psychiatry 34 (6): 402–405.

    Article  CAS  Google Scholar 

  • Gardner D.L. and Cowdry R.W. (1986) Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 143: 519–522.

    PubMed  CAS  Google Scholar 

  • Gasperini M., Battaglia M., Scherillo P., Sciuto G., Diaferia G., and Bellodi L. (1991) Morbidity risk for mood disorders in the families of borderline patients. J Affective Disord 21: 265–272.

    Article  CAS  Google Scholar 

  • George A. and Soloff P.H. (1986) Schizotypal symptoms in patients with Borderline Personality Disorders. Am J Psychiatry 143: 2.

    Google Scholar 

  • Giakas W.J., Seibyl J.P., and Mazure C.M. (1990) Valproate in the treatment of temper outbursts (letter). J Clin Psychiatry 51: 525.

    PubMed  CAS  Google Scholar 

  • Gitlin M.J. (1993) Pharmacotherapy of Personality Disorders: conceptual framework and clinical strategies. J Clin Psychopharmacol 13: 343–353.

    PubMed  CAS  Google Scholar 

  • Goldberg S.C., Schulz C., Schulz P.M., Resnick R.J., Hamer R.M., and Friedel R.O. (1986) Borderline and schizotypal personality disorders treated with low-dose thiothixene versus placebo. Arch Gen Psychiatry 43: 680–686.

    Article  PubMed  CAS  Google Scholar 

  • Gunderson J.G. and Phillips K.A. (1991) A current view of the interface between borderline personality disorder and depression. Am J Psichiatry 148: 8 967–975.

    CAS  Google Scholar 

  • Hasan M.Y., Sewell R.D.E., and Nicholls P.J. (1990) Does the anticonvulsant agent sodium valproate display behaviorally selective anti-offensive activity? (abstract) J Pharm Pharmacol 42 (Suppl): 185.

    Google Scholar 

  • Hirschfeld R.M. (1997) Pharmacotherapy of borderline personality disorder. J Clin Psychiatry 58 (Suppl14): 48–52.

    PubMed  CAS  Google Scholar 

  • Hollander E., Stein D.J., DeCaria C.M., Cohen L., Saoud J.B., Skodol A.E., Kellman D., Rosnick L., and Oldham J.M. (1994) Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry 151: 2 277–280.

    PubMed  CAS  Google Scholar 

  • Hull J.W., Clarkin J.E, and Alexopoulos G.S. (1993) Time series analysis of intervention effects. Fluoxetine therapy as a case illustration. J Nery Ment Dis 181: 48–53.

    Google Scholar 

  • Jonas J.M. and Pope H.G. (1984) Psychosis in borderline personality disorder. Psychiatr Dev 4:295–308. Kane J., Honigfeld G., Singer J., and Meltzer H. (1988) Clozapine for the treatment-resistant schizophrenia. Arch Gen Psychiatry 45: 789–796.

    Google Scholar 

  • Kavoussi R.J., Liu J., and Coccaro E.F. (1994) An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 55: 137–141.

    PubMed  CAS  Google Scholar 

  • Keck EE., McElroy S.L., and Friedman L.M. (1992) Valproate and carbamazepine in the treatment of panic and post-traumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 12 (Suppl 1): 36–41.

    Article  Google Scholar 

  • Kutcher S., Papatheodorou G., Reiter S., and Gardner D. (1995) The successful pharmacological treatment of adolescents and young adults with borderline personality disorders: a preliminary open trial of flupenthixol. J Psychiat Neurosci 20: 113–118.

    CAS  Google Scholar 

  • Lahmeyer H.W., Reynolds C.F., Kupfer D.J., and King R. (1989) Biologic markers in borderline personality disorder: a review. J Clin Psychiatry 50: 217–225.

    PubMed  CAS  Google Scholar 

  • Leone F.N. (1982) Response of borderline patients to loxapine and chlorpromazine J Clin Psychiatry 43: 148–150.

    CAS  Google Scholar 

  • Links P.S., Steiner M., and Huxley G. (1988) The occurence of borderline personality disorder in the families of borderline patients. J Personality Disord 2: 14–20.

    Article  Google Scholar 

  • Links P.S., Steiner M., Boiago I., and Irwin D. (1990) Lithium therapy for borderline patients: preliminary findings. J Personality Disord 4: 173–181.

    Article  Google Scholar 

  • Loranger A.W., Oldham J.M., and Tulis E.H. (1982) Familial transmission of borderline personality. Arch Gen Psychiatry 39: 795–802.

    Article  PubMed  CAS  Google Scholar 

  • Markowitz P.J., Calabrese J.R., Schulz S.C., and Meltzer H.Y. (1991) Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 148: 1064–1067.

    Google Scholar 

  • Mattes J. (1990) Comparative effectiveness of carbamazepine and propanolol for rage outbursts. J Neuropsychiatry Clin Neurosci 2: 159–164.

    PubMed  CAS  Google Scholar 

  • Montgomery S.A. and Montgomery D. (1982) Pharmacological prevention of suicidal behavior. J Affect Disord 4: 291–298.

    Article  PubMed  CAS  Google Scholar 

  • Montgomery S.A., Roy D., and Montgomery D.B. (1987) The prevention of recurrent suicidal acts. Br J Clin Pharmacol 15: 1835–1885.

    Google Scholar 

  • Moss H.B., Yao J.K., and Panzak L. (1990) Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 28: 325–338.

    Article  PubMed  CAS  Google Scholar 

  • Norden M.J. (1989) Fluoxetine in borderline personality disorder. Progr Neuropsychopharmacol Biol Psychiatry 13: 885–893.

    Article  CAS  Google Scholar 

  • Nurnberg H.G., Raskin M., Levine PE., Pollack S., Siegel O., and Prince R. (1991) The comorbidity of borderline personality disorder and other DSM-III-R Axis II personality disorders. Am J Psychiatry 148: 10 1371–1377.

    PubMed  CAS  Google Scholar 

  • Pfohl B., Stangl D., and Zimmerman M. (1984) The implications of DSM III personality disorders for patients with major depression. J Affective Disord 7: 309–318.

    Article  CAS  Google Scholar 

  • Pope H.G., Jonas J.M., Hudson J.I., Cohen B.M., and Gunderson J.C. (1983) The validity of DSM-III borderline personality disorder. Arch Gen Psychiatry 40: 23–30.

    Article  PubMed  Google Scholar 

  • Pope H.G., Jonas J.M., Hudson J.I., Cohen B.M., and Tohen M. (1985) An empirical study of psychosis in borderline personality disorder. Am J Psychiatry 142: 1285–1290.

    PubMed  Google Scholar 

  • Rogers J.H., Wiediger T.A., and Krupp A. (1995) Aspects of depression associated with borderline personality disorder. Am J Psychiatry 152: 268–270.

    PubMed  CAS  Google Scholar 

  • Rosenberg R. (1994) Borderline states: pharmacotherapy in psychobiology of personality. Acta Psychiatr Scand 89 (Suppl 379): 56–60.

    Article  Google Scholar 

  • Salzman C., Wolfson A.N., Schatzberg A., Looper J., Henke R., Albanese M., Schwartz J., and Miyawaki E. (1995) Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15: 23–29.

    Article  PubMed  CAS  Google Scholar 

  • Schulz P.M., Kelly T., Di Franco R. et al. (1986) Borderline personality disorder: family histories, in CME Syllabus and scientific Proceedings in Summary Form, 139th Annual Meeting of the American Psychiatric Association. Washington, DC, APA.

    Google Scholar 

  • Serban G. and Siegel S. (1984) Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 141: 1455–1458.

    PubMed  CAS  Google Scholar 

  • Shader R.I., Jackson A.H., and Dodes L.M. (1974) The antiaggressive effect of lithium in man. Psychopharmacology 40: 17–24.

    Article  CAS  Google Scholar 

  • Shea M.T., Glass D.R., Pilkonis P.A. et al. (1987) Frequency and implications of personality disorders in a sample of depressed outpatients. J Personality Disord 1: 27–42.

    Article  Google Scholar 

  • Sheard M.H. (1975) Lithium in the treatment of aggression. J Nery Ment Dis 160: 108–118.

    Article  CAS  Google Scholar 

  • Skodal A., Buckley P, and Charles E. (1983) Is there a characteristic pattern to the treatment history of clinical outpatients with borderline personality? J Nery Ment Dis 171: 405–410.

    Article  Google Scholar 

  • Siever L.J., Amin F., Coccaro E.F., Bernstein D., Kavoussi R.J., Kalus O., Horvath T.B., Warne P, Davidson M., and Davis K.L. (1991) Plasma homovanillic acid in schizotypal personality disorder. Am J Psychiatry 148: 1246–1248.

    PubMed  CAS  Google Scholar 

  • Siever L.J., Amin F., Coccaro E.F., Trestmann R., Silvermann J., Horvath T.B., Mahon T.R., Knott P., Altstiel L., Davidson M., and Davis K.L. (1993) CSF homovanillic acid in schizotypal personality disorder. Am J Psychiatry 150: 149–151.

    PubMed  CAS  Google Scholar 

  • Silverman J.M., Pinkhan L., Horvath T.B., Coccaro E.F., Klar H., Shear S., Apter S., Davidson M., Mohs R.C., and Siever L.J. (1991) Affective and impulsive personality disorder traits in the relatives of borderline personality disorder. Am J Psychiatry 148: 1378–1385.

    PubMed  CAS  Google Scholar 

  • Soloff P.H. and Millwdrd J.W. (1983) Psychiatric disorders in the families of borderline patients. Arch Gen Psychiatry 40: 37–44.

    Article  PubMed  CAS  Google Scholar 

  • Soloff PH., George A., Nathan R.S., Schulz P.M., Ulrich R.F., and Perel J.M. (1986a) Progress in pharmacotherapy of borderline disorders. A double blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry 43: 691–697.

    Google Scholar 

  • Soloff P.H., George A., Nathan R.S., Schulz P.M., and Perel J.M. (1986b) Paradoxical effects of amitriptyline on borderline patients. Am J Psychiatry 143: 12 1603–1605.

    PubMed  CAS  Google Scholar 

  • Soloff PH., George A., Nathan R.S., Schulz P.M., Cornelius J.R., Herring J., and Perel J.M. (1989) Amitryptiline versus haloperidol in borderlines: final outcome and predictors of response. J Clin Psychopharmacol 9: 238–246.

    Article  PubMed  CAS  Google Scholar 

  • Soloff PH., Cornelius J., George A., Nathan S., Perel J.M., and Ulrich R.E (1993) Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 50: 377–385.

    Article  PubMed  CAS  Google Scholar 

  • Soloff PH. (1994) Is there any drug treatment of choice for the borderline patient? Acta Psychiatr Scand 89 (Suppl 379): 50–55.

    Article  Google Scholar 

  • Southwick S.M., Yehuda R., and Giller E.L. (1995) Psychological dimensions of depression in borderline personality disorder. Am J Psychiatry 152: 789–791.

    PubMed  CAS  Google Scholar 

  • Stein G. (1992) Drug treatment of the personality disorders. Br J Psychiatry 161: 167–184.

    Article  PubMed  CAS  Google Scholar 

  • Stein M.R., Simeon D., Frenkel M., Islam M.N., and Hollander E. (1995) An open trial of valproate in borderline personality disorder. J Clin Psychiatry 56: 506–510.

    PubMed  CAS  Google Scholar 

  • Steinert T., Schmidt-Michel P.O., and Kaschka W.P. (1996) Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type, under treatment with clozapine. Pharmacopsychiatry 29: 111–114.

    Article  PubMed  CAS  Google Scholar 

  • Stone M.H. (1989) The role of pharmacotherapy in the treatment of patients with bordeline personality disorder. Psychopharmacol Bull 25: 564–571.

    PubMed  CAS  Google Scholar 

  • Tamminga C.A., Thaker G.K., Moran M., Kakigi T., and Gao X.M. (1994) Clozapine in tardive dyskinesia: observations from human and animal model studies. J Clin Psychiatry 55: 102–106.

    PubMed  Google Scholar 

  • Verkes R.J., Fekkes D., Zwinderman A.H., Hengeveld M.W., Van der Maast R.C., Tuyl J.P., Kerkhof A.J., and Van Kempen G.M. (1997) Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior. Psychopharmacology 132: 89–94.

    Article  PubMed  CAS  Google Scholar 

  • Verkes R.J., Van der Maast R.C., Kerkhof A.J., Fekkes D., Hengeveld M.W., Tuyl J.P., and Van Kempen G.M. (1998) Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol Psychiatry 43: 740–746.

    Article  PubMed  CAS  Google Scholar 

  • Watkins S.E., Callender K., Thomas D.R., Tidmarsh S.F., and Shaw D.M. (1987) The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 150: 180–182.

    Article  PubMed  CAS  Google Scholar 

  • Wilcox J.A. (1995) Divalproex sodium as a treatment for borderline personality disorder. Ann Clin Psychiatry 7: 33–37.

    Article  PubMed  CAS  Google Scholar 

  • Zanarini M.C., Gunderson J.G., Marino M.F. et al. (1988) DSM-III disorders in the families of borderline outpatients. J Personality Disord 2: 4292–4302.

    Article  Google Scholar 

  • Zanarini M.C., Gunderson J.G., and Frankenburg F.R. (1989) Axis I phenomenology of borderline personality disorder. Compr Psychiatry 30: 149–156.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto Scientifico Ospedale San Raffaele Department of Neuropsychiatric Sciences School of Medicine, University of Milan, Via Prinetti 29, 20127, Milano, Italy

    F. Benedetti, C. Colombo, L. Sforzini, C. Maffei & E. Smeraldi

Authors
  1. F. Benedetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Sforzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Maffei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Smeraldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Nijmegen, Nijmegen, The Netherlands

    Jan Derksen

  2. Free University of Brussels, Brussels, Belgium

    Jan Derksen

  3. Vita-Salute San Raffaele University and Scientific Institute San Raffaele, Milan, Italy

    Cesare Maffei

  4. Forensic Psychiatric Institute “Oldenkotte”, Rekker, The Netherlands

    Herman Groen

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Benedetti, F., Colombo, C., Sforzini, L., Maffei, C., Smeraldi, E. (1999). New Drugs in the Treatment of Borderline Personality Disorder. In: Derksen, J., Maffei, C., Groen, H. (eds) Treatment of Personality Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6876-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6876-3_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3326-3

  • Online ISBN: 978-1-4757-6876-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation